Yahoo Web Search

Search results

    • Q3 2024 Aytu Biopharma Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 hour ago

      As I mentioned, our ADHD portfolio demonstrated a 49% year-over-year increase in net revenue during the third quarter to $12.3 million. The growth in net revenue was driven by strong sales force ...